Soluble LOX‐1 (sLOX‐1) is generated through proteolytic cleavage of the extracellular domain of LOX‐1 and, therefore, sLOX‐1 can be utilized to distinguish acute coronary syndrome, acute spontaneous intracerebral hemorrhage, and acute ischemic stroke (Inoue et al., 2019; Misaka et al., 2014; Yokota et al., 2016). Here, OLR1 is linked to acute coronary syndrome.